eF-site ID 4wo0-AB
PDB Code 4wo0
Chain A, B

click to enlarge
Title Crystal structure of transthyretin in complex with apigenin
Classification TRANSPORT PROTEIN
Compound Transthyretin
Source Homo sapiens (Human) (TTHY_HUMAN)
Sequence A:  CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKT
SESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHE
HAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
B:  CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKT
SESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHE
HAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
Description


Functional site

1) chain A
residue 15
type
sequence K
description binding site for residue AGI A 201
source : AC1

2) chain A
residue 15
type
sequence K
description binding site for residue AGI A 201
source : AC1

3) chain A
residue 17
type
sequence L
description binding site for residue AGI A 201
source : AC1

4) chain A
residue 17
type
sequence L
description binding site for residue AGI A 201
source : AC1

5) chain A
residue 108
type
sequence A
description binding site for residue AGI A 201
source : AC1

6) chain A
residue 110
type
sequence L
description binding site for residue AGI A 201
source : AC1

7) chain A
residue 117
type
sequence S
description binding site for residue AGI A 201
source : AC1

8) chain A
residue 117
type
sequence S
description binding site for residue AGI A 201
source : AC1

9) chain A
residue 118
type
sequence T
description binding site for residue AGI A 201
source : AC1

10) chain A
residue 119
type
sequence T
description binding site for residue AGI A 201
source : AC1

11) chain A
residue 119
type
sequence T
description binding site for residue AGI A 201
source : AC1

12) chain B
residue 15
type
sequence K
description binding site for residue AGI B 201
source : AC2

13) chain B
residue 15
type
sequence K
description binding site for residue AGI B 201
source : AC2

14) chain B
residue 17
type
sequence L
description binding site for residue AGI B 201
source : AC2

15) chain B
residue 108
type
sequence A
description binding site for residue AGI B 201
source : AC2

16) chain B
residue 110
type
sequence L
description binding site for residue AGI B 201
source : AC2

17) chain B
residue 117
type
sequence S
description binding site for residue AGI B 201
source : AC2

18) chain B
residue 117
type
sequence S
description binding site for residue AGI B 201
source : AC2

19) chain B
residue 118
type
sequence T
description binding site for residue AGI B 201
source : AC2

20) chain B
residue 119
type
sequence T
description binding site for residue AGI B 201
source : AC2

21) chain B
residue 119
type
sequence T
description binding site for residue AGI B 201
source : AC2

22) chain A
residue 15-30
type prosite
sequence KVLDAVRGSPAINVAV
description TRANSTHYRETIN_1 Transthyretin signature 1. KVLDavrGsPAinVaV
source prosite : PS00768

23) chain A
residue 105-117
type prosite
sequence YTIAALLSPYSYS
description TRANSTHYRETIN_2 Transthyretin signature 2. YTIAalLSPYSYS
source prosite : PS00769

24) chain A
residue 98
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19167329
source Swiss-Prot : SWS_FT_FI5

25) chain B
residue 98
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19167329
source Swiss-Prot : SWS_FT_FI5

26) chain A
residue 10
type MOD_RES
sequence C
description Sulfocysteine => ECO:0000269|PubMed:17175208, ECO:0007744|PDB:2H4E
source Swiss-Prot : SWS_FT_FI2

27) chain B
residue 10
type MOD_RES
sequence C
description Sulfocysteine => ECO:0000269|PubMed:17175208, ECO:0007744|PDB:2H4E
source Swiss-Prot : SWS_FT_FI2

28) chain A
residue 42
type MOD_RES
sequence E
description 4-carboxyglutamate; in a patient with Moyamoya disease => ECO:0000269|PubMed:18221012
source Swiss-Prot : SWS_FT_FI3

29) chain B
residue 42
type MOD_RES
sequence E
description 4-carboxyglutamate; in a patient with Moyamoya disease => ECO:0000269|PubMed:18221012
source Swiss-Prot : SWS_FT_FI3

30) chain A
residue 52
type MOD_RES
sequence S
description Phosphoserine => ECO:0000250|UniProtKB:P02767
source Swiss-Prot : SWS_FT_FI4

31) chain B
residue 52
type MOD_RES
sequence S
description Phosphoserine => ECO:0000250|UniProtKB:P02767
source Swiss-Prot : SWS_FT_FI4

32) chain B
residue 54
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1

33) chain B
residue 15
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1

34) chain B
residue 117
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1

35) chain A
residue 117
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1

36) chain A
residue 15
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1

37) chain A
residue 54
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:11418763, ECO:0007744|PDB:1ICT
source Swiss-Prot : SWS_FT_FI1


Display surface

Download
Links